Biologic Treatment Outcomes in Refractory Bullous Pemphigoid: An Evidence Base Review

Published: 6 June 2022| Version 1 | DOI: 10.17632/fcswf74g3x.1
Contributor:
Abe Mula

Description

Bullous pemphigoid (BP) is an autoimmune disorder characterized by tense blisters, urticarial plaques and intense pruritis. Initial treatment typically involves the use of topical and oral steroids; however, non-steroidal agents and biologics can also be used in refractory cases. This systematic review examines the treatment outcomes in BP refractory to conventional therapies, treated with biologics.

Files

Categories

Dermatology

License